Surface plasmon resonance analysis for the screening of anti-prion compounds

Satoshi Kawatake, Yuki Nishimura, Suehiro Sakaguchi, Toru Iwaki, Katsumi Doh-Ura

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The interaction of anti-prion compounds and amyloid binding dyes with a carboxy-terminal domain of prion protein (PrP121-231) was examined using surface plasmon resonance (SPR) and compared with inhibition activities of abnormal PrP formation in scrapie-infected cells. Most examined compounds had affinities for PrP121-231: antimalarials had low affinities, whereas Congo red, phthalocyanine and thioflavin S had high affinities. The SPR binding response correlated with the inhibition activity of abnormal PrP formation. Several drugs were screened using SPR to verify the findings: propranolol was identified as a new anti-prion compound. This fact indicates that drug screenings by this assay are useful.

Original languageEnglish
Pages (from-to)927-932
Number of pages6
JournalBiological and Pharmaceutical Bulletin
Volume29
Issue number5
DOIs
Publication statusPublished - May 1 2006

Fingerprint

Surface Plasmon Resonance
Prions
Congo Red
Scrapie
Preclinical Drug Evaluations
Antimalarials
Amyloid
Propranolol
Coloring Agents
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

Surface plasmon resonance analysis for the screening of anti-prion compounds. / Kawatake, Satoshi; Nishimura, Yuki; Sakaguchi, Suehiro; Iwaki, Toru; Doh-Ura, Katsumi.

In: Biological and Pharmaceutical Bulletin, Vol. 29, No. 5, 01.05.2006, p. 927-932.

Research output: Contribution to journalArticle

Kawatake, Satoshi ; Nishimura, Yuki ; Sakaguchi, Suehiro ; Iwaki, Toru ; Doh-Ura, Katsumi. / Surface plasmon resonance analysis for the screening of anti-prion compounds. In: Biological and Pharmaceutical Bulletin. 2006 ; Vol. 29, No. 5. pp. 927-932.
@article{5c52d84ae01d487385531ffb5372cdbc,
title = "Surface plasmon resonance analysis for the screening of anti-prion compounds",
abstract = "The interaction of anti-prion compounds and amyloid binding dyes with a carboxy-terminal domain of prion protein (PrP121-231) was examined using surface plasmon resonance (SPR) and compared with inhibition activities of abnormal PrP formation in scrapie-infected cells. Most examined compounds had affinities for PrP121-231: antimalarials had low affinities, whereas Congo red, phthalocyanine and thioflavin S had high affinities. The SPR binding response correlated with the inhibition activity of abnormal PrP formation. Several drugs were screened using SPR to verify the findings: propranolol was identified as a new anti-prion compound. This fact indicates that drug screenings by this assay are useful.",
author = "Satoshi Kawatake and Yuki Nishimura and Suehiro Sakaguchi and Toru Iwaki and Katsumi Doh-Ura",
year = "2006",
month = "5",
day = "1",
doi = "10.1248/bpb.29.927",
language = "English",
volume = "29",
pages = "927--932",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "5",

}

TY - JOUR

T1 - Surface plasmon resonance analysis for the screening of anti-prion compounds

AU - Kawatake, Satoshi

AU - Nishimura, Yuki

AU - Sakaguchi, Suehiro

AU - Iwaki, Toru

AU - Doh-Ura, Katsumi

PY - 2006/5/1

Y1 - 2006/5/1

N2 - The interaction of anti-prion compounds and amyloid binding dyes with a carboxy-terminal domain of prion protein (PrP121-231) was examined using surface plasmon resonance (SPR) and compared with inhibition activities of abnormal PrP formation in scrapie-infected cells. Most examined compounds had affinities for PrP121-231: antimalarials had low affinities, whereas Congo red, phthalocyanine and thioflavin S had high affinities. The SPR binding response correlated with the inhibition activity of abnormal PrP formation. Several drugs were screened using SPR to verify the findings: propranolol was identified as a new anti-prion compound. This fact indicates that drug screenings by this assay are useful.

AB - The interaction of anti-prion compounds and amyloid binding dyes with a carboxy-terminal domain of prion protein (PrP121-231) was examined using surface plasmon resonance (SPR) and compared with inhibition activities of abnormal PrP formation in scrapie-infected cells. Most examined compounds had affinities for PrP121-231: antimalarials had low affinities, whereas Congo red, phthalocyanine and thioflavin S had high affinities. The SPR binding response correlated with the inhibition activity of abnormal PrP formation. Several drugs were screened using SPR to verify the findings: propranolol was identified as a new anti-prion compound. This fact indicates that drug screenings by this assay are useful.

UR - http://www.scopus.com/inward/record.url?scp=33646441879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646441879&partnerID=8YFLogxK

U2 - 10.1248/bpb.29.927

DO - 10.1248/bpb.29.927

M3 - Article

C2 - 16651721

AN - SCOPUS:33646441879

VL - 29

SP - 927

EP - 932

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 5

ER -